Items where authors include "Yusof, MYM"

Number of items: 7.

Article

Yusof, MYM, Vital, EM orcid.org/0000-0003-1637-4755, Emery, P orcid.org/0000-0002-7429-8482 et al. (1 more author) (2020) Response to “Increased awareness of hypogammaglobulinemia after B‐cell targeting therapies” by Karim MY. Arthritis & Rheumatology, 72 (7). pp. 1231-1233. ISSN 2326-5191

Garcia-Montoya, L, Villota-Eraso, C, Yusof, MYM et al. (2 more authors) (2020) Lessons for rituximab therapy in patients with rheumatoid arthritis. The Lancet Rheumatology. ISSN 2665-9913

Yusof, MYM, Iqbal, K, Darby, M et al. (6 more authors) (2020) Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis. Rheumatology. ISSN 1462-0324

Zayat, AS, Mahmoud, K, Yusof, MYM et al. (8 more authors) (2019) Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus. Rheumatology, 58 (2). key277. pp. 304-312. ISSN 1462-0324

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Yusof, MYM et al. (8 more authors) (2018) Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. ARTN 14846. ISSN 2045-2322

Conference or Workshop Item

Arnold, J, Vital, E, Dass, S et al. (5 more authors) (2021) A Personalised Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in Anca-Associated Vasculitis. In: EULAR 2021, 02-05 Jun 2021, Virtual.

Yusof, MYM, Vital, E, Dass, S et al. (5 more authors) (2013) Safety of rituximab for remission maintenance in relapsing anca–associated vasculitis: repeat cycles on clinical relapse are associated with low rates of hypogammaglobulinaemia. In: Annual European Congress of Rheumatology EULAR, 12-15 Jun 2013, Spain.

This list was generated on Thu Apr 3 12:53:15 2025 BST.